HLB Science (XKRX:343090) Debt-to-Asset : 0.00 (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Debt-to-Asset?

HLB Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. HLB Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. HLB Science's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₩0.00 Mil.

HLB Science Debt-to-Asset Historical Data

The historical data trend for HLB Science's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Debt-to-Asset Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Debt-to-Asset

1.43

0.28

HLB Science Quarterly Data

Debt-to-Asset

Competitive Comparison of HLB Science's Debt-to-Asset

For the Biotechnology subindustry, HLB Science's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where HLB Science's Debt-to-Asset falls into.

HLB Science Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

HLB Science's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(104.186	+	1004.794)	/	3950.314
	=	0.28

HLB Science's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

HLB Science (XKRX:343090) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

HLB Science Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of HLB Science's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines